Skip to content
OpenCapital
Get started

MiNK Therapeutics, Inc. INKT Q1 2026 Annual earnings

Reported May 15, 2026 · Before market open

EPS-$0.57Beat by $0.20
EPS estimate-$0.77

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.60

Versus estimates

Diluted EPS

Q1 2026-$0.57Beat by $0.20
Q4 2025-$0.52Beat by $0.16Q3 2025-$0.65Beat by $0.21Q2 2025-$1.06Miss by $0.51Q1 2025-$0.70Miss by $0.09Q4 2024-$0.62Miss by $0.12

Ask the moment MiNK Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MiNK Therapeutics, Inc. report Q1 2026 earnings?
MiNK Therapeutics, Inc. (INKT) reported Q1 2026 earnings on May 15, 2026 before market open.
What were MiNK Therapeutics, Inc.'s Q1 2026 revenue and EPS?
MiNK Therapeutics, Inc. reported eps of $-0.57 for Q1 2026.
Did MiNK Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.77 by $0.20.
How did MiNK Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 18.6% from $-0.70.
Where can I find MiNK Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-225369) and the 10-K periodic report (0001193125-26-134813) directly on SEC EDGAR. The filing index links above go to sec.gov.